WLLW vs. SUGR, TGOD, NINE, MDP, WMD, DB, HEXO, VIR, ZOM, and META
Should you be buying Willow Biosciences stock or one of its competitors? The main competitors of Willow Biosciences include SugarBud Craft Growers (SUGR), Green Organic Dutchman (TGOD), Delta 9 Cannabis (NINE), Medexus Pharmaceuticals (MDP), WeedMD (WMD), Decibel Cannabis (DB), HEXO (HEXO), Viridium Pacific Group (VIR), Zomedica Pharmaceuticals Corp. (ZOM.V) (ZOM), and Meta Growth (META). These companies are all part of the "drug manufacturers - specialty & generic" industry.
Willow Biosciences vs. Its Competitors
SugarBud Craft Growers (CVE:SUGR) and Willow Biosciences (TSE:WLLW) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, media sentiment, risk, analyst recommendations, earnings and institutional ownership.
In the previous week, SugarBud Craft Growers' average media sentiment score of 0.00 equaled Willow Biosciences'average media sentiment score.
SugarBud Craft Growers has a net margin of 2.11% compared to Willow Biosciences' net margin of -268.91%. SugarBud Craft Growers' return on equity of 10.07% beat Willow Biosciences' return on equity.
SugarBud Craft Growers has higher revenue and earnings than Willow Biosciences. Willow Biosciences is trading at a lower price-to-earnings ratio than SugarBud Craft Growers, indicating that it is currently the more affordable of the two stocks.
0.4% of SugarBud Craft Growers shares are owned by institutional investors. Comparatively, 0.1% of Willow Biosciences shares are owned by institutional investors. 30.2% of SugarBud Craft Growers shares are owned by company insiders. Comparatively, 24.3% of Willow Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
SugarBud Craft Growers has a beta of 2.768948, suggesting that its stock price is 177% more volatile than the S&P 500. Comparatively, Willow Biosciences has a beta of 1.13, suggesting that its stock price is 13% more volatile than the S&P 500.
Summary
SugarBud Craft Growers beats Willow Biosciences on 10 of the 11 factors compared between the two stocks.
Get Willow Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for WLLW and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding WLLW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Willow Biosciences Competitors List
Related Companies and Tools
This page (TSE:WLLW) was last updated on 9/6/2025 by MarketBeat.com Staff
Free WLLW Stock Alerts